The Safety and Efficacy of Rituximab-Based Regimen in Atypical Membranous Nephropathy: A Single Center Retrospective Cohort Study.

Yanan Liu, Shuo Zhang,Rongrong Hu,Chao Li,Gang Chen,Xiaoxiao Shi,Yan Liu,Ke Zheng,Hang Li,Yubing Wen,Xuemei Li,Xuewang Li,Peng Xia,Yan Qin

International journal of general medicine（2023）

引用 0|浏览13

暂无评分

摘要

In our study, AMN patients obtained proteinuria remission in a lower percentage compared with IMN patients. In general, rituximab-based therapy is effective in AMN patients with an acceptable safety profile.

查看译文

关键词

rituximab, atypical membranous nephropathy, idiopathic membranous nephropathy, efficacy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要